Inspire welcomes Jeff Trotter as Chief Science Officer

The leading patient-centered health platform strengthens commitment to scientific and strategic excellence in real-world trials

Jeff Trotter, Chief Science Officer, Inspire

Inspire appoints Jeff Trotter, RWE Pioneer, as Chief Science OfficerInspire appoints Jeff Trotter, RWE Pioneer, as Chief Science Officer
Inspire appoints Jeff Trotter, RWE Pioneer, as Chief Science Officer

Arlington, VA, Oct. 29, 2024 (GLOBE NEWSWIRE) — Inspire, the world’s largest online health community, today announced the appointment of Jeff Trotter as Chief Science Officer (CSO). With over 40 years of pioneering experience in health economics, outcomes research and real-world evidence (RWE), Trotter brings unparalleled expertise to the Inspire leadership team. He will support Inspire and its customers on a consultative basis, driving innovation and ensuring that patient-centred solutions are aligned with the latest science strategy.

Trotter’s career spans the clinical development and commercialization landscape, having founded leading consultancies and served in executive roles at several prominent contract research organizations. A recognized expert in observational studies, patient registries and real-world data (RWD), Trotter will leverage his extensive knowledge to enhance Inspire’s data-driven offerings for biopharma, medical device companies and sectors other life sciences.

“We are thrilled to have Jeff join our team in this key role,” said Brett Kleger, CEO of Inspire. “His deep understanding of real-world evidence and his background in research design and implementation will be invaluable as Inspire continues to grow. Jeff’s insights have already played a crucial role in advancing our RWE services and the role of His expanded role marks an important milestone for our company as we enter a new phase of growth.”

In addition to his advisory role with Inspire, Trotter will continue to lead J Trotter Research & Consulting, providing strategic guidance to a broader group of clients. His dual responsibilities will enable a unique cross-pollination of knowledge between Inspire’s state-of-the-art patient-centric platform and its independent consultancy, benefiting all parties involved.

“I am excited to deepen my collaboration with Inspire at this transformative time,” said Trotter. “Inspire’s ability to harness the voices and real-world experiences of its 10 million patients across a variety of medical conditions is truly unmatched. I look forward to contributing to the company’s mission to bring valuable insights to the life sciences industry and ultimately improve outcomes for patients, caregivers and healthcare providers.”

Trotter will also serve on Inspire’s Advisory Board, providing strategic direction for future initiatives and ensuring that Inspire’s RWE solutions continue to meet the evolving needs of its customers by advancing patient care along the clinical development and commercialization continuum. . Join Inspire at the IMPACCT RWE Summit to learn more about how our patient-centric platform and real-world validation solutions are driving innovation in the life sciences industry.

About Inspire

Founded in 2005, Inspire is the leading health community, connecting over 10 million patients and caregivers in 3,000 disease areas. Through its powerful patient-centric platform, Inspire supports initiatives across the clinical development lifecycle—from preclinical research to post-market access—enabling life sciences organizations to capture real-world insights and accelerate medical breakthroughs. For more information, visit www.inspire.com.

Attachment

CONTACT: Jillian Tygh Inspire 267-254-3997 [email protected]